576 related articles for article (PubMed ID: 25758254)
1. Epigenetic-related therapeutic challenges in cardiovascular disease.
Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
3. Impact of epigenetics in the management of cardiovascular disease: a review.
Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular epigenetics: from DNA methylation to microRNAs.
Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.
Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C
Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674
[TBL] [Abstract][Full Text] [Related]
6. Advances in epigenetic regulation of vascular aging.
Jin J; Liu Y; Huang L; Tan H
Rev Cardiovasc Med; 2019 Mar; 20(1):19-25. PubMed ID: 31184092
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins.
Declerck K; Szarc vel Szic K; Palagani A; Heyninck K; Haegeman G; Morand C; Milenkovic D; Vanden Berghe W
Curr Top Med Chem; 2016; 16(7):788-806. PubMed ID: 26303416
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Lee PS; Chiou YS; Ho CT; Pan MH
Biofactors; 2018 Jan; 44(1):26-35. PubMed ID: 29220106
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic effects of nano-sized materials.
Stoccoro A; Karlsson HL; Coppedè F; Migliore L
Toxicology; 2013 Nov; 313(1):3-14. PubMed ID: 23238276
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic associations in relation to cardiovascular prevention and therapeutics.
Voelter-Mahlknecht S
Clin Epigenetics; 2016; 8():4. PubMed ID: 26779291
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic effects of physical activity in elderly patients with cardiovascular disease.
Recchioni R; Marcheselli F; Antonicelli R; Mensà E; Lazzarini R; Procopio AD; Olivieri F
Exp Gerontol; 2017 Dec; 100():17-27. PubMed ID: 29074290
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular diseases: Interplay of epigenetics.
Ahuja YR; Sharma S; Mohan V
Clin Exp Hypertens; 2017; 39(1):1-7. PubMed ID: 28055289
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and disease targets by polyphenols.
Pan MH; Lai CS; Wu JC; Ho CT
Curr Pharm Des; 2013; 19(34):6156-85. PubMed ID: 23448446
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular System.
Sharma S; Mishra A; Ashraf MZ
Adv Exp Med Biol; 2020; 1229():121-132. PubMed ID: 32285408
[TBL] [Abstract][Full Text] [Related]
16. Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.
Hodjat M; Rahmani S; Khan F; Niaz K; Navaei-Nigjeh M; Mohammadi Nejad S; Abdollahi M
Arch Toxicol; 2017 Jul; 91(7):2577-2597. PubMed ID: 28516248
[TBL] [Abstract][Full Text] [Related]
17. Nutriepigenetics and cardiovascular disease.
Kalea AZ; Drosatos K; Buxton JL
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):252-259. PubMed ID: 29847446
[TBL] [Abstract][Full Text] [Related]
18. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
Napoli C; Coscioni E; de Nigris F; Donatelli F
Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
[TBL] [Abstract][Full Text] [Related]
19. The role of redox signaling in epigenetics and cardiovascular disease.
Kim GH; Ryan JJ; Archer SL
Antioxid Redox Signal; 2013 May; 18(15):1920-36. PubMed ID: 23480168
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulations in nanoparticle-mediated toxicity.
Wong BSE; Hu Q; Baeg GH
Food Chem Toxicol; 2017 Nov; 109(Pt 1):746-752. PubMed ID: 28689059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
